Related Experiment Video
Updated: May 2, 2026
06:57
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
7.7K
Defining severity in non-cystic fibrosis bronchiectasis
Lucy Poppelwell1, James D Chalmers
1Tayside Respiratory Research Group, University of Dundee, Dundee, DD1 9SY UK.
Expert Review of Respiratory Medicine
|March 8, 2014
Summary
Defining severe bronchiectasis is crucial for patient care and treatment. New research is identifying risk factors to establish clearer definitions for mild, moderate, and severe disease, improving clinical decisions.
Area of Science:
- Pulmonology
- Clinical Medicine
Background:
- Bronchiectasis significantly impacts patient quality of life and healthcare systems.
- Historically considered an orphan disease, bronchiectasis now has emerging treatments.
- Accurate disease severity assessment is vital for clinical management.
Purpose of the Study:
- To address the lack of agreed-upon definitions for mild, moderate, and severe bronchiectasis.
- To propose new definitions for severe bronchiectasis based on identified risk factors.
- To enhance clinical decision-making and guide the application of new therapies.
Main Methods:
- Reviewing studies that define risk factors for mortality, hospital admissions, exacerbations, and impaired quality of life in bronchiectasis.
- Analyzing computed tomography (CT) findings in relation to disease impact.
- Synthesizing current research to propose novel severity classifications.
Main Results:
- Current definitions of bronchiectasis severity often rely on radiological appearances, which lack precision.
- Emerging studies are identifying key risk factors associated with adverse outcomes.
- There is a growing need for precise definitions to guide treatment and prognosis.
Conclusions:
- Improved understanding of bronchiectasis severity and prognosis is essential.
- New definitions based on risk factors will aid clinical decision-making.
- This will facilitate the effective application of emerging and novel therapies for bronchiectasis.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:24Cystic Fibrosis: Management
657
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
657
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30